Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Amstad

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|February 7, 2020
Growth differentiation factor 15 is increased in stable MSAndrea Amstad, Mali Coray, Corina Frick, et al.
Rheumatology (Oxford, England)|May 17, 2022
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapyAndrea Amstad, Eleftherios Papagiannoulis, Almut Scherer, et al.
Swiss Medical Weekly|March 25, 2025
VEXAS syndrome: a Swiss national retrospective cohort studyLouis Wolff, Leo Caratsch, Fabian Lötscher, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Neurology(R) Neuroimmunology & Neuroinflammation|February 7, 2020
Growth differentiation factor 15 is increased in stable MSAndrea Amstad, Mali Coray, Corina Frick, et al.
Rheumatology (Oxford, England)|May 17, 2022
Comparison of drug retention of TNF inhibitors, other biologics and JAK inhibitors in RA patients who discontinued JAK inhibitor therapyAndrea Amstad, Eleftherios Papagiannoulis, Almut Scherer, et al.
Swiss Medical Weekly|March 25, 2025
VEXAS syndrome: a Swiss national retrospective cohort studyLouis Wolff, Leo Caratsch, Fabian Lötscher, et al.
Pageof 1